Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy.
about
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsResistance Development: A Major Piece in the Jigsaw Puzzle of Tumor Size Modeling.Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma.
P2860
Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy.
@en
type
label
Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy.
@en
prefLabel
Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy.
@en
P2093
P2860
P356
P1476
Therapy's Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy
@en
P2093
Andrei Mogoutov
Nicole C Nelson
Peter Keating
P2860
P356
10.3389/FPHAR.2013.00058
P577
2013-05-07T00:00:00Z